Visualization of endolymphatic hydrops in meánieàre's disease with single-dose intravenous gadolinium-based contrast media using heavily T2-weighted 3D-FLAIR

Magnetic Resonance in Medical Sciences

Volumn 9, Issue 4, 2010, Pages 237-242

  Naganawa, Shinji ^a   Yamazaki, Masahiro ^a   Kawai, Hisashi ^a   Bokura, Kiminori ^a   Sone, Michihiko ^a   Nakashima, Tsutomu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

3D imaging; Advanced imaging techniques; Magnetic resonance imaging; Me nie re's disease

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOTERIDOL; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; CASE REPORT; COCHLEA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENIERE DISEASE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; THREE DIMENSIONAL IMAGING;

ADULT; AGED, 80 AND OVER; COCHLEA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ENDOLYMPHATIC HYDROPS; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MENIERE DISEASE; MIDDLE AGED; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS;

EID: 79955686765     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.9.237     Document Type: Article

References (12)

1. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meánieàre's disease. Laryngoscope 2007; 117: 415-420.
2. Fukuoka H, Tsukada K, Miyagawa M, et al. Semiquantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based con- trast agent (GBCA) administration with MRI for Meánieàre's disease. Acta Otolaryngol 2010; 130:10-16.
3. Zou J, Poe D, Bjelke B, Pyykko I. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol Suppl 2009 Feb; (560):22-31.
4. Nakashima T, Naganawa S, Teranishi M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meánieàre's disease. Acta Otolaryngol 2010; 130:338-343.
5. Naganawa S, Nakashima T. Cutting edge of inner ear MRI. Acta Otolaryngol Suppl 2009 Feb; (560): 15-21.
6. Tagaya M, Teranishi M, Naganawa S, et al. 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010; 130: 665-669.
7. Naganawa S, Satake H, Iwano S, Fukatsu H, Sone M, Nakashima T. Imaging endolymphatic hydrops at 3 tesla using 3D-FLAIR with intratympanic Gd- DTPA administration. Magn Reson Med Sci 2008; 7:85-91.
8. Lane JI, Witte RJ, Bolster B, Bernstein MA, Johnson K, Morris J. State of the art: 3T imaging of the membranous labyrinth. AJNR Am J Neuroradiol 2008; 29:1436-1440.
9. Naganawa S, Kawai H, Sone M, Nakashima T. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3DFLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010; 9:73-80.
10. Wiggins GC, Triantafyllou C, Potthast A, Reykowski A, Nittka M, Wald LL. 32-channel 3 Tesla receive-only phased-array head coil with soccer-ball element geometry. Magn Reson Med 2006; 56:216-223.
11. Nakashima T, Naganawa S, Pyykko I, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009 Feb; (560):5-8.
12. Naganawa S, Komada T, Fukatsu H, Ishigaki T, Takizawa O. Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006; 16:733-737.